The primary objective of this clinical trial is to evaluate the performance of the Nvision Volumetric Laser Endomicroscopy (VLE) system to visualize subsurface tissue in subjects undergoing esophagogastroduodenoscopy (EGD) and to identify work-flow and training implications for introducing this new imaging modality.
Study Type
OBSERVATIONAL
Enrollment
120
Mayo Clinic
Jacksonville, Florida, United States
Mayo Clinic
Rochester, Massachusetts, United States
VA Medical Center
Kansas City, Missouri, United States
Primary Effectiveness Endpoint
The primary endpoint will be the number of subjects achieving completed VLE imaging studies at the time of EDG.
Time frame: The research participants will be followed and evaluated for the duration of their VLE procedure, an expected average of 10 additional minutes beyond the standard EDG procedure.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.